Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.230
-0.050 (-3.91%)
At close: Apr 28, 2026, 4:00 PM EDT
1.260
+0.030 (2.44%)
After-hours: Apr 28, 2026, 7:14 PM EDT
Pulmonx Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Pulmonx stock have an average target of 5.38, with a low estimate of 2.50 and a high estimate of 14. The average target predicts an increase of 337.40% from the current stock price of 1.23.
Analyst Consensus: Buy
* Price targets were last updated on Mar 5, 2026.
Analyst Ratings
The average analyst rating for Pulmonx stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +306.50% | Mar 5, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,038.21% | Mar 5, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,038.21% | Feb 20, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,038.21% | Nov 13, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $8 → $4 | Strong Buy | Maintains | $8 → $4 | +225.20% | Oct 28, 2025 |
Financial Forecast
Revenue This Year
92.74M
from 90.50M
Increased by 2.48%
Revenue Next Year
109.86M
from 92.74M
Increased by 18.46%
EPS This Year
-1.16
from -1.33
EPS Next Year
-0.87
from -1.16
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 95.9M | 158.7M | ||||||
| Avg | 92.7M | 109.9M | ||||||
| Low | 88.2M | 92.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 6.0% | 71.2% | ||||||
| Avg | 2.5% | 18.5% | ||||||
| Low | -2.5% | -0.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.17 | -0.09 | ||||||
| Avg | -1.16 | -0.87 | ||||||
| Low | -1.15 | -1.11 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.